One pathology, two morphologies: Plasma cell crystalline inclusions in monoclonal gammopathy of undetermined significance

A man in his sixties, with a 2-month history of lower rib pain and generalised weakness, was diagnosed with monoclonal gammopathy of undetermined significance (MGUS). The bone marrow aspirate was normocellular with trilineage haematopoiesis, revealing less than 10% monoclonal plasma cells (characterised as a monotypic, cytoplasmic kappa light chain-restricted CD38+, CD138+ population with dim CD45 expression). A subset of these plasma cells exhibited round, inconspicuous nucleoli and contained intracytoplasmic, non-birefringent translucent crystalline structures, rhomboid in shape (upper panel, May-Grünwald Giemsa [MGG], ×100 objective). Upon admission, laboratory evaluation revealed a haemoglobin level of 120 g/L (normal: 135–175 g/L). Serum protein electrophoresis, immunofixation and free light-chain (FLC) studies identified a monoclonal immunoglobulin G (IgG) kappa of 13 g/L with normal FLC values. A low-dose whole-body computed tomography scan showed no lytic lesions. The anaemia and rib pain resolved within weeks. One year later, a follow-up bone marrow aspirate was performed due to worsening anaemia (95 g/L), though the monoclonal protein level remained stable. The aspirate again revealed less than 10% monoclonal plasma cell infiltration but with a different morphology, showing abundant intracytoplasmic crystalline structures, now more rectangular or square-shaped (bottom panel, MGG, ×100 objective). In the absence of disease progression, simple monitoring was continued. Also, no symptoms of Fanconi syndrome were observed during this period, contrary to what is typically seen in similar cases with plasma cell crystalline inclusions. This case highlights the unusual plasma cell morphology in the context of MGUS at two distinct time points. The presence of intracellular crystalline inclusions, although rare, is a recognised phenomenon. The abnormal trafficking of microvesicles, originating from the Golgi apparatus and driven by excessive immunoglobulin production, may lead to fusion with lysosomes and limited proteolysis. This process results in the crystallisation of light chain fragments, contributing to the formation of crystalline inclusions in these plasma cells. The presence of crystalline inclusions has been hypothesised to correlate with a non-progressive clinical course, though its prognostic significance remains largely undefined due to the rarity of this morphological feature. The author did not receive support from any organization for the submitted work. This manuscript respects the ethic policy of CHU Lyon for the treatment of human research participants. The author has confirmed that a patient consent statement is not required for this submission, as no patient-identifying data were used. The author declares no use of third-party material in this study for which formal permission is required.

Authors

Institutions

Publication Details

Journal
British Journal of Haematology
Published
2025-03-11
DOI
https://doi.org/10.1111/bjh.20017
Citations
1
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

One pathology, two morphologies: Plasma cell crystalline inclusions in monoclonal gammopathy of undetermined significance

Radu Chiriac
1 citations
British Journal of Haematology
Multiple Myeloma Research and Treatments
1.77
article

One pathology, two morphologies: Plasma cell crystalline inclusions in monoclonal gammopathy of undetermined significance

Radu Chiriac
article en
1 citations

Abstract

A man in his sixties, with a 2-month history of lower rib pain and generalised weakness, was diagnosed with monoclonal gammopathy of undetermined significance (MGUS). The bone marrow aspirate was normocellular with trilineage haematopoiesis, revealing less than 10% monoclonal plasma cells (characterised as a monotypic, cytoplasmic kappa light chain-restricted CD38+, CD138+ population with dim CD45 expression). A subset of these plasma cells exhibited round, inconspicuous nucleoli and contained intracytoplasmic, non-birefringent translucent crystalline structures, rhomboid in shape (upper panel, May-Grünwald Giemsa [MGG], ×100 objective). Upon admission, laboratory evaluation revealed a haemoglobin level of 120 g/L (normal: 135–175 g/L). Serum protein electrophoresis, immunofixation and free light-chain (FLC) studies identified a monoclonal immunoglobulin G (IgG) kappa of 13 g/L with normal FLC values. A low-dose whole-body computed tomography scan showed no lytic lesions. The anaemia and rib pain resolved within weeks. One year later, a follow-up bone marrow aspirate was performed due to worsening anaemia (95 g/L), though the monoclonal protein level remained stable. The aspirate again revealed less than 10% monoclonal plasma cell infiltration but with a different morphology, showing abundant intracytoplasmic crystalline structures, now more rectangular or square-shaped (bottom panel, MGG, ×100 objective). In the absence of disease progression, simple monitoring was continued. Also, no symptoms of Fanconi syndrome were observed during this period, contrary to what is typically seen in similar cases with plasma cell crystalline inclusions. This case highlights the unusual plasma cell morphology in the context of MGUS at two distinct time points. The presence of intracellular crystalline inclusions, although rare, is a recognised phenomenon. The abnormal trafficking of microvesicles, originating from the Golgi apparatus and driven by excessive immunoglobulin production, may lead to fusion with lysosomes and limited proteolysis. This process results in the crystallisation of light chain fragments, contributing to the formation of crystalline inclusions in these plasma cells. The presence of crystalline inclusions has been hypothesised to correlate with a non-progressive clinical course, though its prognostic significance remains largely undefined due to the rarity of this morphological feature. The author did not receive support from any organization for the submitted work. This manuscript respects the ethic policy of CHU Lyon for the treatment of human research participants. The author has confirmed that a patient consent statement is not required for this submission, as no patient-identifying data were used. The author declares no use of third-party material in this study for which formal permission is required.

British Journal of HaematologyVol. 206(5)
Hospices Civils de Lyon (FR), Hôpital Lyon Sud (FR)
Openalex Percentile: Top 18%
Multiple Myeloma Research and Treatments
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.